» Articles » PMID: 23144549

Virtual Screening of ABCC1 Transporter Nucleotidebinding Domains As a Therapeutic Target in Multidrug Resistant Cancer

Overview
Journal Bioinformation
Specialty Biology
Date 2012 Nov 13
PMID 23144549
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: ABCC1 is a member of the ATP-binding Cassette super family of transporters, actively effluxes xenobiotics from cells. Clinically, ABCC1 expression is linked to cancer multidrug resistance. Substrate efflux is energised by ATP binding and hydrolysis at the nucleotide-binding domains (NBDs) and inhibition of these events may help combat drug resistance. The aim of this study is to identify potential inhibitors of ABCC1 through virtual screening of National Cancer Institute (NCI) compounds. A threedimensional model of ABCC1 NBD2 was generated using MODELLER whilst the X-ray crystal structure of ABCC1 NBD1 was retrieved from the Protein Data Bank. A pharmacophore hypothesis was generated based on flavonoids known to bind at the NBDs using PHASE, and used to screen the NCI database. GLIDE was employed in molecular docking studies for all hit compounds identified by pharmacophore screening. The best potential inhibitors were identified as compounds possessing predicted binding affinities greater than ATP. Approximately 5% (13/265) of the hit compounds possessed lower docking scores than ATP in ABCC1 NBD1 (NSC93033, NSC662377, NSC319661, NSC333748, NSC683893, NSC226639, NSC94231, NSC55979, NSC169121, NSC166574, NSC73380, NSC127738, NSC115534), whereas approximately 7% (7/104) of docked NCI compounds were predicted to possess lower docking scores than ATP in ABCC1 NBD2 (NSC91789, NSC529483, NSC211168, NSC318214, NSC116519, NSC372332, NSC526974). Analyses of docking orientations revealed P-loop residues of each NBD and the aromatic amino acids Trp653 (NBD1) and Tyr1302 (NBD2) were key in interacting with high-affinity compounds. On the basis of docked orientation and docking score the compounds identified may be potential inhibitors of ABCC1 and require further pharmacological analysis.

Abbreviations: ABC - ATP-binding cassette, DHS - dehydrosilybin, MDR - multidrug resistance, NBD - nucleotide-binding domain, PDB - protein data bank.

Citing Articles

Non-coding polymorphisms in nucleotide binding domain 1 in ABCC1 gene associate with transcript level and survival of patients with breast cancer.

Kunicka T, Vaclavikova R, Hlavac V, Vrana D, Pecha V, Raus K PLoS One. 2014; 9(7):e101740.

PMID: 25078270 PMC: 4117604. DOI: 10.1371/journal.pone.0101740.


Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma.

Wangari-Talbot J, Hopper-Borge E J Can Res Updates. 2014; 2(4):265-282.

PMID: 24634705 PMC: 3952141. DOI: 10.6000/1929-2279.2013.02.04.5.


Tranilast binds to aβ monomers and promotes aβ fibrillation.

Connors C, Rosenman D, Lopes D, Mittal S, Bitan G, Sorci M Biochemistry. 2013; 52(23):3995-4002.

PMID: 23679559 PMC: 4082028. DOI: 10.1021/bi400426t.

References
1.
Hung L, Wang I, NIKAIDO K, Liu P, AMES G, Kim S . Crystal structure of the ATP-binding subunit of an ABC transporter. Nature. 1999; 396(6712):703-7. DOI: 10.1038/25393. View

2.
Deeley R, Cole S . Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 2006; 580(4):1103-11. DOI: 10.1016/j.febslet.2005.12.036. View

3.
di Pietro A, Conseil G, Perez-Victoria J, Dayan G, Baubichon-Cortay H, Trompier D . Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol Life Sci. 2002; 59(2):307-22. PMC: 11146118. DOI: 10.1007/s00018-002-8424-8. View

4.
Schiller M . Minimotif miner: a computational tool to investigate protein function, disease, and genetic diversity. Curr Protoc Protein Sci. 2008; Chapter 2:Unit 2.12. DOI: 10.1002/0471140864.ps0212s48. View

5.
Ramaen O, Masscheleyn S, Duffieux F, Pamlard O, Oberkampf M, Lallemand J . Biochemical characterization and NMR studies of the nucleotide-binding domain 1 of multidrug-resistance-associated protein 1: evidence for interaction between ATP and Trp653. Biochem J. 2003; 376(Pt 3):749-56. PMC: 1223803. DOI: 10.1042/BJ20030998. View